Head and Neck Cancer Market Global Industry Analysis, Size, Share, Growth, Trends, And Forecast 2017 - 2025

Global Head and Neck Cancer Market: Key Segments

Based on drug class, the global head and neck cancer market has been segmented into EFGR inhibitors, mitotic inhibitors, anti-PD-1 monoclonal antibodies, and others. The segments have been analyzed based on available drug product used during the treatment of head and neck cancer, cost-effectiveness, and preference for industries. In terms of distribution channel, the global market has been classified into hospital pharmacies, retail pharmacies, and e-commerce. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Head and Neck Cancer Market: Regional Outlook

In terms of region, the global head and neck cancer market has been segmented into five major regions: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global head and neck cancer market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Sanofi, Pfizer, Eli Lilly and Company, Merck KgaA, Bristol-Myers Squibb Company, Bayer AG, Galera, Fresenius Kabi, and Teva Pharmaceuticals.

The global head and neck cancer market has been segmented as below:

Global Head and Neck Cancer Market, by Drug Class
EGFR Inhibitors
Mitotic Inhibitors
Anti-PD-1 Monoclonal Antibodies
Others
Global Head and Neck Cancer Market, by Distribution Channel
Hospitals Pharmacies
Retail Pharmacies
E-commerce
Global Head and Neck Cancer Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.